ARK Investment Management LLCARK Investment Management LLC

Institutional investor · Portfolio as of Q4 2020

SEC EDGAR SourceSEC Filings

Top Holdings244 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

TESLA INC

4.1M$2.9B7.8%$135.83+70.51%
9 qtrssince 2018-Q4
Increased
74

ROKU INC

5.4M$1.8B4.7%$178.71+89.55%
7 qtrssince 2019-Q2
Increased
76

CRISPR THERAPEUTICS AG

10.4M$1.6B4.2%$78.19+106.64%
9 qtrssince 2018-Q4
Increased
71

TELADOC HEALTH INC

7.8M$1.6B4.2%$204.43-0.42%
9 qtrssince 2018-Q4
Increased
94

BLOCK INC

7.1M$1.5B4.1%$94.87+132.98%
9 qtrssince 2018-Q4
Increased
70
NVTAQNVTAQDelisted

INVITAE CORP

27M$1.1B3.0%
9 qtrssince 2018-Q4
Decreased
0

PURE STORAGE INC - CLASS A

41.2M$930.7M2.5%$18.33+25.10%
4 qtrssince 2020-Q1
Increased
79

ZILLOW GROUP INC - C

6.5M$841.3M2.2%$108.50+20.23%
2 qtrssince 2020-Q3
Increased
70

Twist Bioscience Corp.

5.9M$830.4M2.2%$98.58+49.28%
7 qtrssince 2019-Q2
Increased
85

SPOTIFY TECHNOLOGY SA

2.4M$741.4M2.0%$283.26+12.74%
9 qtrssince 2018-Q4
Increased
81

PACIFIC BIOSCIENCES CALIF IN

28.5M$739.4M2.0%$13.06+101.83%
7 qtrssince 2019-Q2
Increased
67

EDITAS MEDICINE INC

10.1M$709.9M1.9%$25.50+200.04%
9 qtrssince 2018-Q4
Decreased
0

IOVANCE BIOTHERAPEUTICS INC

15.3M$709.8M1.9%$38.01+28.28%
9 qtrssince 2018-Q4
Increased
79
EXASEXASDelisted

EXACT SCIENCES CORP

5.3M$703.8M1.9%$132.07+2.52%
2 qtrssince 2020-Q3
Increased
80

PROTO LABS INC

4.1M$632M1.7%$120.38+30.79%
9 qtrssince 2018-Q4
Increased
64

INTELLIA THERAPEUTICS INC

11.2M$608.8M1.6%$14.25+297.14%
9 qtrssince 2018-Q4
Decreased
0

TWILIO INC - A

1.8M$607.2M1.6%$290.08+20.50%
9 qtrssince 2018-Q4
Increased
80

PAYPAL HOLDINGS INC

2.6M$605.3M1.6%$222.96+3.60%
9 qtrssince 2018-Q4
Increased
80

LENDINGTREE INC

2M$550.4M1.5%$272.76+0.79%
9 qtrssince 2018-Q4
Increased
68

SHOPIFY INC - CLASS A

481,101$544.6M1.4%$116.27+0.03%
9 qtrssince 2018-Q4
Increased
80
$37.6B
AUM
244
Positions
Q4 2020
Filing
Rating · 4.0
Quarterly Portfolio Change
+15%Q3'19$4.6B-13%Q4'19$4B+1%Q1'20$4B+132%Q2'20$9.3B+81%Q3'20$16.9B+123%Q4'20$37.6B
Activity profile
$ moved · Q4'20
New10%Increased81%Decreased9%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q10%1-4Q16%1-2Y18%2Y+56%

ARK Investment Management LLC manages $37.6B across 244 positions as of Q4 2020. Top holdings: TSLA (7.8%), ROKU (4.7%), CRSP (4.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q4 2020 Summary

Active quarter - 27 new positions, 6 exits, 190 increased. Top move: TDOC (INCREASED, conviction 94). Portfolio: $37.6B across 244 positions.

Top holdings by portfolio weight

Total AUM$38B
TSLA7.76%
ROKU4.75%
CRSP4.24%
TDOC4.17%
XYZ4.10%
NVTAQ3.00%
PSTG2.48%
Z2.24%
TWST2.21%
SPOT1.97%
Other1.97%

Portfolio allocation by GICS sector

Sectors10
Healthcare32.68%
Technology21.79%
Communication Services16.88%
Consumer Cyclical11.01%
Unknown8.38%
Financial Services5.12%
Industrials2.61%
Real Estate1.33%
Consumer Defensive0.20%
Basic Materials0.01%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Communication Services
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track RecordNo data
Conviction44
Concentration59
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
GOOGGOOGALPHABET INC-CL C
Q3 2024 Q2 2026+915,979 shares+$345.3M
6Q
AVAVAVAVAEROVIRONMENT INC
Q1 2025 Q2 2026+343,875 shares+$59.7M
6Q
ISRGISRGINTUITIVE SURGICAL INC
Q1 2025 Q2 2026+50,925 shares+$17.8M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used